UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$850M |
| 2 |
Apple
AAPL
|
+$778M |
| 3 |
Tesla
TSLA
|
+$569M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$351M |
| 5 |
Johnson & Johnson
JNJ
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Meta Platforms (Facebook)
META
|
+$237M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$223M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$217M |
| 5 |
Vertiv
VRT
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.83% |
| 2 | Healthcare | 7.49% |
| 3 | Financials | 7.15% |
| 4 | Consumer Discretionary | 4.92% |
| 5 | Industrials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CS
3026
DELISTED
Credit Suisse Group
CS
| $2.82M | ﹤0.01% |
929,147
+79,777
| +9% | +$310K |
|
3027
PJT Partners
PJT
$4.33B
| $2.82M | ﹤0.01% |
38,298
+2,204
| +6% | +$165K |
|
3028
CALL
Royal Bank of Canada
RY
$293B
| $2.82M | ﹤0.01% |
+30,000
| New | +$2.83M |
|
|
3029
PUT
Royal Bank of Canada
RY
$293B
| $2.82M | ﹤0.01% |
+30,000
| New | +$2.83M |
|
3030
uniQure
QURE
$3.2B
| $2.82M | ﹤0.01% |
124,388
+75,730
| +156% | +$1.63M |
|
3031
PUT
iRhythm Holdings
IRTC
$4.1B
| $2.81M | ﹤0.01% |
30,000
| – | – |
|
|
AGEN
3032
Agenus
AGEN
$291M
| $2.81M | ﹤0.01% |
59,632
+49,957
| +516% | +$2.54M |
|
3033
Digital Turbine
APPS
$1.74B
| $2.81M | ﹤0.01% |
184,151
-59,464
| -24% | -$914K |
|
3034
SouthState Bank Corp
SSB
$10.5B
| $2.8M | ﹤0.01% |
36,714
+10,634
| +41% | +$893K |
|
3035
DaVita
DVA
$11.7B
| $2.8M | ﹤0.01% |
37,535
-2,614
| -7% | -$203K |
|
|
CDMO
3036
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.8M | ﹤0.01% |
203,537
+178,974
| +729% | +$2.74M |
|
3037
Nuveen New York Municipal Value Fund
NNY
$156M
| $2.8M | ﹤0.01% |
338,895
+42,460
| +14% | +$350K |
|
|
CNR
3038
Core Natural Resources Inc
CNR
$4.67B
| $2.8M | ﹤0.01% |
43,039
+38,822
| +921% | +$2.62M |
|
|
DAWN
3039
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.79M | ﹤0.01% |
129,857
+108,251
| +501% | +$2.22M |
|
3040
Insight Enterprises
NSIT
$4.54B
| $2.79M | ﹤0.01% |
27,863
+8,535
| +44% | +$815K |
|
3041
Recursion Pharmaceuticals
RXRX
$1.76B
| $2.79M | ﹤0.01% |
361,895
+343,430
| +1,860% | +$3.37M |
|
3042
CALL
Spotify
SPOT
$105B
| $2.79M | ﹤0.01% |
35,300
+300
| +0.9% | +$24.2K |
|
3043
Cracker Barrel
CBRL
$1.25B
| $2.79M | ﹤0.01% |
29,412
+12,888
| +78% | +$1.34M |
|
3044
WisdomTree Global High Dividend Fund
DEW
$155M
| $2.79M | ﹤0.01% |
59,515
-753
| -1% | -$34.1K |
|
3045
PUT
Fastly Inc
FSLY
$4.42B
| $2.78M | ﹤0.01% |
340,000
| – | – |
|
3046
Gabelli Equity Trust
GAB
$1.79B
| $2.78M | ﹤0.01% |
508,035
+126,534
| +33% | +$703K |
|
3047
Prospect Capital
PSEC
$1.15B
| $2.78M | ﹤0.01% |
397,994
-12,954
| -3% | -$93.1K |
|
3048
Qualys
QLYS
$6.43B
| $2.78M | ﹤0.01% |
24,786
+15,683
| +172% | +$1.96M |
|
3049
PUT
Lazard
LAZ
$4.16B
| $2.78M | ﹤0.01% |
80,200
+79,800
| +19,950% | +$2.84M |
|
|
DCPH
3050
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.78M | ﹤0.01% |
169,340
+128,397
| +314% | +$2.09M |
|
Similar funds
UBS Group's Q4 2022 Portfolio in Review
As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.
- UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
- UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
- UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
- UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
- UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
- UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
- UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.
Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.